Alpha-glycerylphosphorylcholine, L-alpha-glycerophosphocholine, Glycerophosphocholine, Alpha-GPC
Alpha-GPC is a choline-containing supplement that is found in a large variety of food products but can be pharmacology activated in high doses as well. Alpha-GPC supplementation increases acetylcholine and choline on the brain, influencing their systemic concentrations. Some athletes use Alpha-GPC due to its capacity for energy enhance before intense activities.
- Origin: Animal Product, Plant Based, Synthetic
- Source: Eggs, Wheat Germs, Soybean, Synthetic
- Type: Nootropics
- Age Range: Adults
- Toxicity: May be toxic in high doses
- Outcomes: Cognitive Function and Brain Health, Memory Enhancer
What are Alpha-GPC benefits?
Alpha-GPC is a choline-rich supplement, and although this substance is also found in several foods, it is pharmacologically active in higher doses in Alpha-GPC. Its trade is focused on nootropic purposes, as studies prove its benefits in reducing cognitive problems and increasing the energy of its consumers by 14%. Alzheimer’s symptoms also drop when consumed daily at a dosage of 1,200mg. It increases iron absorption and fat oxidation and stimulates growth hormone. In a few minutes quiz, you find out ways to improve your health and whether Alpha-GPC can help you with that. Check it out!
Table of relations
Alpha-GPC and Cognitive Function and Brain Health
-
Memory Enhancer
Memory lapses are common, after all, who has never forgotten a name or address? In an age of information bombardment, our brain filters what is or is not important to be stored. With these filters, we have the long and short-term memory, in which our brain divides what will be used frequently and what will not be recurrent, like a computer HD. The first happens to many people and is about forgetting common information such as telephone numbers, while the second reflects the loss of memory of moments in life or names of children. However, for these lapses not to become frequent it is important that there is a preventive care with the memory, thus it is possible to avoid greater damage to the cognitive health of this area.
Related videos about Alpha-GPC
References
- ^ a b Hoffman JR, et al. The effects of acute and prolonged CRAM supplementation on reaction time and subjective measures of focus and alertness in healthy college students. J Int Soc Sports Nutr. (2010)
- ^ a b c Di Perri R, et al. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia. J Int Med Res. (1991)
- ^ a b A neurotropic approach to the treatment of multi-infarct dementia using L-α-glycerylphosphorylcholine.
- ^ a b Amenta F, et al. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer’s disease with cerebrovascular injury: interim results. J Neurol Sci. (2012)
- ^ a b c d e f Tayebati SK, et al. Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain. CNS Neurol Disord Drug Targets. (2013)
- ^ a b c d e Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr. (1981)
- ^ a b c Scapicchio PL. Revisiting choline alphoscerate profile: a new, perspective, role in dementia. Int J Neurosci. (2013)
- ^ a b c Zhang K, et al. Purification of L-alpha glycerylphosphorylcholine by column chromatography. J Chromatogr A. (2012)
- ^ a b c Armah CN, et al. L-alpha-glycerophosphocholine contributes to meat’s enhancement of nonheme iron absorption. J Nutr. (2008)
- ^ SCHMIDT G, HERSHMAN B, THANNHAUSER SJ. The isolation of alpha-glycerylphosphorylcholine from incubated beef pancreas; its significance for the intermediary metabolism of lecithin. J Biol Chem. (1945)
- ^ Brockerhoff H, Yurkowski M. Simplified preparation of L-alpha-glyceryl phosphoryl choline. Can J Biochem. (1965)
- ^ a b c d Brownawell AM, Carmines EL, Montesano F. Safety assessment of AGPC as a food ingredient. Food Chem Toxicol. (2011)
- ^ a b c d e f g h i j k l Concentrations of Choline-Containing Compounds and Betaine in Common Foods.
- ^ Gatti G, et al. A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. Int J Clin Pharmacol Ther Toxicol. (1992)
- ^ Parnetti L, et al. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation. J Neurol Sci. (2007)
- ^ Amenta F, et al. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission. Mech Ageing Dev. (2006)
- ^ Tayebati SK, et al. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats. J Neurol Sci. (2009)
- ^ Subbaiah PV, Ganguly J. Studies on the phospholipases of rat intestinal mucosa. Biochem J. (1970)
- ^ Lecithinase and lysolecithinase of intestinal mucosa.
- ^ Absorption of lipids.
- ^ Parthasarathy S, Subbaiah PV, Ganguly J. The mechanism of intestinal absorption of phosphatidylcholine in rats. Biochem J. (1974)
- ^ ENZYME: 3.1.4.2.
- ^ The transphosphatidylation activity of phospholipase D.
- ^ Le Kim D, Betzing H. Intestinal absorption of polyunsaturated phosphatidylcholine in the rat. Hoppe Seylers Z Physiol Chem. (1976)
- ^ Subbaiah PV, Ganguly J. Transesterification of lysolecithin in the intestinal mucosa of rats. Indian J Biochem. (1971)
- ^ a b c d Kawamura T, et al. Glycerophosphocholine enhances growth hormone secretion and fat oxidation in young adults. Nutrition. (2012)
- ^ a b Tayebati SK, Amenta F. Choline-containing phospholipids: relevance to brain functional pathways. Clin Chem Lab Med. (2013)
- ^ Klein J, et al. Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int. (1993)
- ^ Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm. (2000)
- ^ a b Abbiati G, et al. Absorption, tissue distribution and excretion of radiolabelled compounds in rats after administration of {14C}-L-alpha-glycerylphosphorylcholine. Eur J Drug Metab Pharmacokinet. (1993)
- ^ a b c Trabucchi M, Govoni S, Battaini F. Changes in the interaction between CNS cholinergic and dopaminergic neurons induced by L-alpha-glycerylphosphorylcholine, a cholinomimetic drug. Farmaco Sci. (1986)
- ^ a b c d e f Sigala S, et al. L-alpha-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. Eur J Pharmacol. (1992)
- ^ Aleppo G, et al. Chronic L-alpha-glyceryl-phosphoryl-choline increases inositol phosphate formation in brain slices and neuronal cultures. Pharmacol Toxicol. (1994)
- ^ a b c Schettini G, et al. Molecular mechanisms mediating the effects of L-alpha-glycerylphosphorylcholine, a new cognition-enhancing drug, on behavioral and biochemical parameters in young and aged rats. Pharmacol Biochem Behav. (1992)
- ^ a b c Lopez CM, et al. Effect of a new cognition enhancer, alpha-glycerylphosphorylcholine, on scopolamine-induced amnesia and brain acetylcholine. Pharmacol Biochem Behav. (1991)
- ^ a b c Tayebati SK, et al. Effect of choline-containing phospholipids on brain cholinergic transporters in the rat. J Neurol Sci. (2011)
- ^ Tomassoni D, et al. Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats. Curr Alzheimer Res. (2012)
- ^ Canal N, et al. Effect of L-alpha-glyceryl-phosphorylcholine on amnesia caused by scopolamine. Int J Clin Pharmacol Ther Toxicol. (1991)
- ^ a b c Ferraro L, et al. Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by alpha-glycerylphosphorylcholine. Neurochem Res. (1996)
- ^ Noradrenergic modulation of cortical acetylcholine release is both direct and gamma-aminobutyric acid-mediated.
- ^ Beani L, et al. Inversion of the alpha-2 and alpha-1 noradrenergic control of the cortical release of acetylcholine and gamma-aminobutyric acid in morphine-tolerant guinea pigs. J Pharmacol Exp Ther. (1988)
- ^ Nelson TJ, et al. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur J Pharmacol. (2008)
- ^ Glanzman DL. PKM and the maintenance of memory. F1000 Biol Rep. (2013)
- ^ Ren SQ, et al. PKCλ is critical in AMPA receptor phosphorylation and synaptic incorporation during LTP. EMBO J. (2013)
- ^ a b Govoni S, et al. PKC translocation in rat brain cortex is promoted in vivo and in vitro by alpha-glycerylphosphorylcholine, a cognition-enhancing drug. Ann N Y Acad Sci. (1993)
- ^ a b c Lucchi L, et al. Cognition stimulating drugs modulate protein kinase C activity in cerebral cortex and hippocampus of adult rats. Life Sci. (1993)
- ^ Wang QJ. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci. (2006)
- ^ a b Govoni S, et al. Protein kinase C increase in rat brain cortical membranes may be promoted by cognition enhancing drugs. Life Sci. (1992)
- ^ a b Nitsch R, et al. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer’s disease. Ann N Y Acad Sci. (1991)
- ^ Wurtman RJ. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci. (1992)
- ^ Wurtman RJ, Blusztajn JK, Maire JC. “Autocannibalism” of choline-containing membrane phospholipids in the pathogenesis of Alzheimer’s disease-A hypothesis. Neurochem Int. (1985)
- ^ Walter A, et al. Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. (2004)
- ^ Yang X, et al. Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity. J Lipid Res. (2010)
- ^ Gentile MT, et al. Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer’s disease pathogenesis. Mol Neurobiol. (2012)
- ^ Milanesi L, et al. Direct three-dimensional visualization of membrane disruption by amyloid fibrils. Proc Natl Acad Sci U S A. (2012)
- ^ De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. (2003)
- ^ a b c Parnetti L, Amenta F, Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mech Ageing Dev. (2001)
- ^ Parnetti L, et al. Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer’s type. Drugs Aging. (1993)
- ^ Barbagallo Sangiorgi G, et al. alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Ann N Y Acad Sci. (1994)
- ^ a b c Alpha-GPC and power output; growth hormone.
- ^ a b Ceda GP, et al. alpha-Glycerylphosphorylcholine administration increases the GH responses to GHRH of young and elderly subjects. Horm Metab Res. (1992)
- ^ a b Agarwal N, et al. Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T. Bipolar Disord. (2010)
- ^ a b Babb SM, et al. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology (Berl). (2002)
- ^ Silveri MM, et al. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy. NMR Biomed. (2008)
- ^ Hurrell RF, et al. Meat protein fractions enhance nonheme iron absorption in humans. J Nutr. (2006)
- ^ Conrad ME, Umbreit JN, Moore EG. Iron absorption and transport. Am J Med Sci. (1999)
- ^ Troesch B, et al. Optimization of a phytase-containing micronutrient powder with low amounts of highly bioavailable iron for in-home fortification of complementary foods. Am J Clin Nutr. (2009)